• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变异株刺突糖蛋白的结构洞察:一项具有潜在临床意义的计算研究

Structural Insights on the SARS-CoV-2 Variants of Concern Spike Glycoprotein: A Computational Study With Possible Clinical Implications.

作者信息

Cueno Marni E, Imai Kenichi

机构信息

Department of Microbiology, Nihon University School of Dentistry, Tokyo, Japan.

出版信息

Front Genet. 2021 Oct 22;12:773726. doi: 10.3389/fgene.2021.773726. eCollection 2021.

DOI:10.3389/fgene.2021.773726
PMID:34745235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8568765/
Abstract

Coronavirus disease 2019 (COVID-19) pandemic has been attributed to SARS-CoV-2 (SARS2) and, consequently, SARS2 has evolved into multiple SARS2 variants driving subsequent waves of infections. In particular, variants of concern (VOC) were identified to have both increased transmissibility and virulence ascribable to mutational changes occurring within the spike protein resulting to modifications in the protein structural orientation which in-turn may affect viral pathogenesis. However, this was never fully elucidated. Here, we generated spike models of endemic HCoVs (HCoV 229E, HCoV OC43, HCoV NL63, HCoV HKU1, SARS CoV, MERS CoV), original SARS2, and VOC (alpha, beta, gamma, delta). Model quality check, structural superimposition, and structural comparison based on RMSD values, TM scores, and contact mapping were all performed. We found that: 1) structural comparison between the original SARS2 and VOC whole spike protein model have minor structural differences (TM > 0.98); 2) the whole VOC spike models putatively have higher structural similarity (TM > 0.70) to spike models from endemic HCoVs coming from the same phylogenetic cluster; 3) original SARS2 S1-CTD and S1-NTD models are structurally comparable to VOC S1-CTD (TM = 1.0) and S1-NTD (TM > 0.96); and 4) endemic HCoV S1-CTD and S1-NTD models are structurally comparable to VOC S1-CTD (TM > 0.70) and S1-NTD (TM > 0.70) models belonging to the same phylogenetic cluster. Overall, we propose that structural similarities (possibly ascribable to similar conformational epitopes) may help determine immune cross-reactivity, whereas, structural differences (possibly associated with varying conformational epitopes) may lead to viral infection (either reinfection or breakthrough infection).

摘要

2019年冠状病毒病(COVID-19)大流行被归因于严重急性呼吸综合征冠状病毒2(SARS-CoV-2,简称SARS2),因此,SARS2已演变成多个SARS2变体,引发了后续的感染浪潮。特别是,令人担忧的变体(VOC)被确定具有更高的传播性和毒力,这归因于刺突蛋白内发生的突变变化,导致蛋白质结构取向发生改变,进而可能影响病毒发病机制。然而,这一点从未得到充分阐明。在此,我们构建了地方性人冠状病毒(HCoV 229E、HCoV OC43、HCoV NL63、HCoV HKU1、SARS-CoV、MERS-CoV)、原始SARS2和VOC(阿尔法、贝塔、伽马、德尔塔)的刺突模型。进行了模型质量检查、结构叠加以及基于均方根偏差值、TM分数和接触图谱的结构比较。我们发现:1)原始SARS2和VOC全刺突蛋白模型之间的结构比较存在微小结构差异(TM>0.98);2)整个VOC刺突模型与来自同一系统发育簇的地方性HCoV刺突模型具有更高的结构相似性(TM>0.70);3)原始SARS2的S1-CTD和S1-NTD模型在结构上与VOC的S1-CTD(TM = 1.0)和S1-NTD(TM>0.96)相当;4)地方性HCoV的S1-CTD和S1-NTD模型在结构上与属于同一系统发育簇的VOC的S1-CTD(TM>0.70)和S1-NTD(TM>0.70)模型相当。总体而言,我们提出结构相似性(可能归因于相似的构象表位)可能有助于确定免疫交叉反应性,而结构差异(可能与不同的构象表位相关)可能导致病毒感染(再次感染或突破性感染)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/9511bf268719/fgene-12-773726-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/7ced87fa9c03/fgene-12-773726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/7390cab5a5eb/fgene-12-773726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/23fa1d7905c5/fgene-12-773726-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/9511bf268719/fgene-12-773726-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/7ced87fa9c03/fgene-12-773726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/7390cab5a5eb/fgene-12-773726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/23fa1d7905c5/fgene-12-773726-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da4/8568765/9511bf268719/fgene-12-773726-g004.jpg

相似文献

1
Structural Insights on the SARS-CoV-2 Variants of Concern Spike Glycoprotein: A Computational Study With Possible Clinical Implications.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变异株刺突糖蛋白的结构洞察:一项具有潜在临床意义的计算研究
Front Genet. 2021 Oct 22;12:773726. doi: 10.3389/fgene.2021.773726. eCollection 2021.
2
Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses.严重急性呼吸综合征冠状病毒2刺突蛋白与其他感染人类冠状病毒的结构比较。
Front Med (Lausanne). 2021 Jan 14;7:594439. doi: 10.3389/fmed.2020.594439. eCollection 2020.
3
Structural patterns of SARS-CoV-2 variants of concern (alpha, beta, gamma, delta) spike protein are influenced by variant-specific amino acid mutations: A computational study with implications on viral evolution.关注的 SARS-CoV-2 变体(阿尔法、贝塔、伽马、德尔塔)刺突蛋白的结构模式受变体特异性氨基酸突变的影响:对病毒进化有影响的计算研究。
J Theor Biol. 2023 Feb 7;558:111376. doi: 10.1016/j.jtbi.2022.111376. Epub 2022 Dec 5.
4
Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.母亲在确诊 COVID-19 PCR、出现病毒症状且未暴露于病毒的情况下,母乳中针对 SARS-CoV-2、HCoV-OC43 和 HCoV-229E 的 S1 和 S2 亚单位的人乳抗体。
Int J Mol Sci. 2021 Feb 9;22(4):1749. doi: 10.3390/ijms22041749.
5
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers.冠状病毒刺突蛋白特异性抗体表明婴儿期和接种 BNT162b2 的医护人员中经常发生感染和再感染。
Sci Rep. 2023 May 24;13(1):8416. doi: 10.1038/s41598-023-35471-3.
6
BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein.BSL2 级相容的 SARS-CoV-2 致死性小鼠模型及其关注变异株,用于评估针对 Spike 蛋白的治疗药物。
Front Immunol. 2022 Jul 28;13:919815. doi: 10.3389/fimmu.2022.919815. eCollection 2022.
7
SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics.SARS-CoV-2 及其他人类冠状病毒:通过分子系统发生学对蛋白酶识别位点、刺突蛋白抗原性变异及其分组的研究。
Infect Genet Evol. 2021 Apr;89:104729. doi: 10.1016/j.meegid.2021.104729. Epub 2021 Jan 23.
8
Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019-July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection.2019年12月至2020年7月期间严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突糖蛋白中类弗林蛋白酶切割位点的结构变异见解:一项将病毒进化与感染联系起来的计算研究
Front Med (Lausanne). 2021 Mar 10;8:613412. doi: 10.3389/fmed.2021.613412. eCollection 2021.
9
SARS-CoV-2 gained a novel spike protein S1-N-Terminal Domain (S1-NTD).SARS-CoV-2 获得了一种新型的刺突蛋白 S1-N 端结构域(S1-NTD)。
Environ Res. 2022 Aug;211:113047. doi: 10.1016/j.envres.2022.113047. Epub 2022 Mar 12.
10
The HCoV-HKU1 N-Terminal Domain Binds a Wide Range of 9--Acetylated Sialic Acids Presented on Different Glycan Cores.HCoV-HKU1 N 端结构域结合了不同糖链核心上广泛存在的 9-乙酰化唾液酸。
ACS Infect Dis. 2024 Nov 8;10(11):3880-3890. doi: 10.1021/acsinfecdis.4c00488. Epub 2024 Oct 12.

引用本文的文献

1
Pre-existing IgG antibodies to HCoVs NL63 and OC43 Spike increased during the pandemic and after COVID-19 vaccination.在大流行期间以及接种新冠疫苗后,针对人冠状病毒NL63和OC43刺突蛋白的预先存在的IgG抗体有所增加。
Heliyon. 2025 Jan 22;11(3):e42171. doi: 10.1016/j.heliyon.2025.e42171. eCollection 2025 Feb 15.
2
Distribution and Functional Analyses of Mutations in Spike Protein and Phylogenic Diversity of SARS-CoV-2 Variants Emerged during the Year 2021 in India.2021年印度出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株刺突蛋白突变的分布与功能分析及系统发育多样性
J Glob Infect Dis. 2023 May 17;15(2):43-51. doi: 10.4103/jgid.jgid_178_22. eCollection 2023 Apr-Jun.
3

本文引用的文献

1
Remember Beta? New data reveal variant's deadly powers.还记得贝塔毒株吗?新数据揭示了该变种的致命威力。
Nature. 2021 Aug 9. doi: 10.1038/d41586-021-02177-3.
2
The emerging SARS-CoV-2 variants of concern.新出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变体。
Ther Adv Infect Dis. 2021 Jun 18;8:20499361211024372. doi: 10.1177/20499361211024372. eCollection 2021 Jan-Dec.
3
Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.SARS-CoV-2 刺突抗原中的免疫优势 T 细胞表位揭示了未暴露个体中存在强大的预先存在的 T 细胞免疫。
Identification of antigens recognized by salivary IgA using microbial protein microarrays.
使用微生物蛋白质微阵列鉴定唾液IgA识别的抗原。
Biosci Microbiota Food Health. 2022;41(4):177-184. doi: 10.12938/bmfh.2022-014. Epub 2022 Jun 6.
4
Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19.在严重 COVID-19 期间,针对地方性冠状病毒刺突蛋白的血清 IgG 和分泌型 IgA 的异源免疫反应。
Front Immunol. 2022 Mar 9;13:839367. doi: 10.3389/fimmu.2022.839367. eCollection 2022.
Sci Rep. 2021 Jun 23;11(1):13164. doi: 10.1038/s41598-021-92521-4.
4
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.截至2021年6月,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的传播性增加及其在全球的传播情况。
Euro Surveill. 2021 Jun;26(24). doi: 10.2807/1560-7917.ES.2021.26.24.2100509.
5
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.接种 BNT162b2 疫苗后针对严重急性呼吸综合征冠状病毒 2 变异株和人类冠状病毒的体液和细胞免疫应答。
Clin Infect Dis. 2021 Dec 6;73(11):2000-2008. doi: 10.1093/cid/ciab555.
6
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
7
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.SARS-CoV-2 关切变异株部分逃避 COVID-19 恢复期患者和疫苗接种者的体液但不逃避 T 细胞反应。
Sci Immunol. 2021 May 25;6(59). doi: 10.1126/sciimmunol.abj1750.
8
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.SARS-CoV-2 可以招募一种血红素代谢物来逃避抗体免疫。
Sci Adv. 2021 May 28;7(22). doi: 10.1126/sciadv.abg7607. Print 2021 May.
9
Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域的构象变化及基于结构数据的B细胞抗原表位预测
Front Artif Intell. 2021 Mar 25;4:630955. doi: 10.3389/frai.2021.630955. eCollection 2021.
10
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.识别 SARS-CoV-2 刺突蛋白主要和次要表位的单克隆抗体的中和效力受 B.1.1.7 变异株的影响。
Immunity. 2021 Jun 8;54(6):1276-1289.e6. doi: 10.1016/j.immuni.2021.03.023. Epub 2021 Apr 1.